<SEC-DOCUMENT>0001193125-21-055966.txt : 20210225
<SEC-HEADER>0001193125-21-055966.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225094629
ACCESSION NUMBER:		0001193125-21-055966
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210225
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nutrien Ltd.
		CENTRAL INDEX KEY:			0001725964
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				981400416
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38336
		FILM NUMBER:		21676929

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
		BUSINESS PHONE:		(306) 933-8500

	MAIL ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d281919d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;13a-16</FONT> or
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of: February, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-38336</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>NUTRIEN LTD. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
registrant) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 500, 122 &#150; 1st Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>South Saskatoon, Saskatchewan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S7K 7G3 Canada </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address
of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F:</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9746;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>NUTRIEN LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: February&nbsp;25, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert A. Kirkpatrick</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert A. Kirkpatrick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SVP&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">News Release dated February&nbsp;25, 2021</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d281919dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 99.1 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g281919g0225061600707.jpg" ALT="LOGO">
<B> </B><B></B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">NYSE, TSX: NTR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right"><B>News Release</B></TD></TR>
</TABLE> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;25,
2021 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Nutrien Announces TSX Approval for Its Renewed Share Repurchase Program </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>SASKATOON, Saskatchewan</B> &#150; Nutrien Ltd. (TSX and NYSE: NTR) (Nutrien) today announced that the Toronto Stock Exchange (TSX) has
accepted Nutrien&#146;s notice to commence a normal course issuer bid (NCIB) to purchase up to five percent of its outstanding common shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the NCIB, purchases of common shares may be made through the facilities of the TSX, the New York Stock Exchange or alternative Canadian
trading systems, or as otherwise permitted by the Canadian Securities Administrators. The actual number of common shares that may be purchased under the NCIB and the timing of any such purchases will be determined by Nutrien. Nutrien believes that
purchasing its own common shares represents an attractive investment opportunity, is in the best interests of the company and is consistent with Nutrien&#146;s objective of delivering a strong return of capital to its shareholders over time. As of
February&nbsp;16, 2021, Nutrien had 569,368,963 common shares outstanding and, therefore, is permitted to repurchase up to 28,468,448 of its outstanding common shares pursuant to the NCIB. Common shares purchased under the NCIB will be cancelled.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The NCIB will be effected in accordance with the TSX normal course issuer bid rules and/or Rule
<FONT STYLE="white-space:nowrap">10b-18</FONT> under the U.S. Securities Exchange Act of 1934, as amended, which contain restrictions on the number of common shares that may be purchased on a single day, subject to certain exceptions for block
purchases, based on the average daily trading volumes of Nutrien&#146;s common shares on the applicable exchange. Subject to exceptions for block purchases, Nutrien will limit daily purchases of common shares on the TSX in connection with the NCIB
to no more than 25&nbsp;percent (357,658 common shares) of the average daily trading volume of the common shares on the TSX (1,430,634 common shares) during any trading day. Purchases under the NCIB will be made through open market purchases at
market price, as well as by other means as may be permitted by applicable securities regulatory authorities, including private agreements. Any purchases made by private agreement under an issuer bid exemption order issued by a securities regulatory
authority will be at a discount to the prevailing market price as provided in any exemption order. Purchases of common shares may commence on March&nbsp;1, 2021 and will expire on the earlier of February&nbsp;28, 2022, the date on which the company
has acquired the maximum number of common shares allowable or otherwise decides not to make any further repurchases. Nutrien has entered into an automatic purchase plan with a broker which will enable Nutrien to provide standard instructions and
purchase common shares on the open market during self-imposed blackout periods. Outside of these <FONT STYLE="white-space:nowrap">black-out</FONT> periods, common shares may be purchased in accordance with management&#146;s discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nutrien&#146;s prior NCIB for the purchase of up to 28,572,458 common shares will expire on February&nbsp;26, 2021. As of February&nbsp;16,
2021, Nutrien has repurchased an aggregate of 710,100 common shares at a weighted-average price of US$39.31 per share, excluding brokerage fees, under the prior NCIB. Purchases were made on the open market. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain statements and other information included in this press release constitute &#147;forward-looking information&#148; or
&#147;forward-looking statements&#148; (collectively, &#147;forward-looking statements&#148;) under applicable securities laws (such statements are usually accompanied by words such as &#147;anticipate&#148;, &#147;expect&#148;, &#147;believe&#148;,
&#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;estimate&#148;, &#147;intend&#148; or other similar words). All statements in this press release, other than those relating to historical information or current conditions, are
forward-looking statements, including, but not limited to the timing, methods and quantity of any purchases by Nutrien of its common shares under the NCIB. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Forward looking statements in this press release are based on certain key expectations and assumptions made by Nutrien, including expectations
and assumptions concerning: Nutrien&#146;s views with respect to its financial condition and prospects, the stability of general economic and market conditions, currency exchange rates and interest rates, the availability of cash for repurchases of
common shares under the NCIB, the existence of alternative uses for Nutrien&#146;s cash resources and compliance with applicable laws and regulations pertaining to the NCIB. Although Nutrien believes that the expectations and assumptions on which
such forward looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Nutrien can give no assurance that they will prove to be correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Forward-looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially
from the anticipated results or expectations expressed in this press release. The key risks and uncertainties include, but are not limited to: Nutrien&#146;s future capital requirements; market and general economic conditions; demand for
Nutrien&#146;s products; and unforeseen legal or regulatory developments and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulatory authorities and the United States Securities and Exchange
Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or
obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Nutrien </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nutrien is the
world&#146;s largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. We produce and distribute 27&nbsp;million tonnes of potash, nitrogen and phosphate products
world-wide. With this capability and our leading agriculture retail network, we are well positioned to supply the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic,
environmental and social priorities. The scale and diversity of our integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR FURTHER INFORMATION: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Downey </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(403) <FONT STYLE="white-space:nowrap">225-7357</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tim Mizuno </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director, Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(306) <FONT
STYLE="white-space:nowrap">933-8548</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Relations </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Megan Fielding </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Brand&nbsp;&amp; Culture
Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(403) <FONT STYLE="white-space:nowrap">797-3015</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact us at: <U>www.nutrien.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g281919g0225061600707.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g281919g0225061600707.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X -D# 2(  A$! Q$!_\0
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M]JR* 2% R>OX5R7P2^(/BCQ'XDN=,U>]:^MA 9 \B*&C(]P!P?>@#WJBBB@
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M2O%/!GCC5_ VJ->Z6T;"1=LL,P)20>^.<^XKO=1_:+\375J8K+3]/LI&&/.
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MT"PZMIMK>QJ<J)X@VT^V>E%% "Z1H>EZ!:M;:386]G S;BD*!03ZU?(#*58
M@C!!'6BB@#D]0^&/@K5)VFNO#ED9&.6:)3%D_P# "*DTSX;>#-(F6:R\.V*R
MJ<J\B&0CZ;R<444 =0    , = *S9/#FAS2-)+HVG22.=S,UJA+'U)Q110!?
M@@AM8%@MXHXHD&%CC4*JCV JO>:3IVHNKWVGVMRR#"F>%7('MD444 +9Z7I^
:G%S8V%K:E_O>1"J;OK@<U;HHH *2BB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
